Core Viewpoint - The chronic pain medical device market in China is expected to grow significantly, driven by factors such as an aging population, increasing prevalence of chronic diseases, improved policy and insurance environments, and technological advancements [5][11]. Market Overview - The sales revenue of China's chronic pain medical device market is projected to reach $386.51 million in 2024 and $720 million by 2031, with a compound annual growth rate (CAGR) of 9.29% from 2025 to 2031 [5]. Industry Concentration and Competition - Major players in the Chinese market include Medtronic, Xiangyu Medical, Boston Scientific, Abbott, and OMRON, with the top three companies holding approximately 55.9% of the market share in 2024 [9]. Development Drivers - The market is primarily driven by three factors: 1. Aging population and high incidence of chronic diseases, leading to increased demand for pain management devices [11]. 2. Improved policies and insurance frameworks that facilitate multi-disciplinary management of pain [11]. 3. Technological advancements, including wearable devices and smart pain management solutions, enhancing personalized treatment options [11]. Challenges - The industry faces several challenges: 1. Fragmented market competition, with international brands dominating high-end segments while domestic companies focus on mid to low-end markets [11]. 2. High regulatory and clinical entry barriers, increasing pressure on small and medium enterprises [11]. 3. Incomplete payment systems, limiting the adoption of certain pain management devices in primary care and home settings [11]. 4. Insufficient awareness among patients and doctors regarding non-drug pain treatments, necessitating further market education [11]. Future Trends - The market is expected to trend towards smart and home-based solutions, with advancements in AI, big data, and IoT enabling remote monitoring and personalized treatment [12]. - The demand for portable and easy-to-use devices is rising, shifting the market focus from hospital-centric to a dual "hospital + home" model [12]. - Domestic innovation and international expansion are anticipated to be key trends, with policies supporting local manufacturers and new market opportunities emerging in regions like Southeast Asia and the Middle East [12]. Policy Framework - The Chinese government emphasizes the development of the medical device sector through various policies aimed at enhancing innovation and competitiveness [13][15]. - Key policies include the "Healthy China 2030" initiative and the "Made in China 2025" plan, which focus on improving the innovation capabilities of medical devices [13][15]. Supply Chain Analysis - The supply chain for chronic pain medical devices includes upstream raw material suppliers such as Nippon Steel and SABIC, and downstream markets comprising hospitals, home care, and rehabilitation centers [19][20]. - The hospital sector is the primary market for high-end devices, while the home care segment is rapidly growing, particularly for non-invasive devices like TENS units [20].

比赛当日，棋盘山滑雪场欢声笑语不断，参赛家庭在专业教练与安全保障团队的协助下，合作完成雪球 开路、极地救援、冰坡行走、雪洞脱险、登顶、雪圈冲线等多个兼具竞技性、趣味性与家庭协作性的项 目。家长们纷纷表示，在冰雪环境中与孩子共同闯关、互相鼓励，是一次难得的亲情体验与成长教育。 本次赛事在国家体育总局登山运动管理中心、中国登山协会指导下，由辽宁省体育局、沈阳棋盘山国际 风景旅游开发区管委会联合主办。作为中国家庭户外运动挑战赛系列赛事的重要一站，同时也是棋盘山 首届大型冰雪主题户外综合赛事，赛事积极响应了国家体育总局"跟着赛事去旅行"的号召，将体育赛事 与地域文旅深度融合，有效带动棋盘山及周边地区的冬季旅游热度，促进消费升级与区域经济活力释 放，不仅为广大家庭提供了亲近自然、挑战自我的冰雪体验平台，也生动诠释了"冰天雪地也是金山银 山"的发展理念，助推户外运动向大众化、家庭化、常态化发展。 总局登山中心相关负责人表示，赛事强化了亲子互动与家庭情感纽带，传播了健康积极的户外运动文 化，为全民健身事业注入了温馨而有力的"家"能量。这不仅是山地户外赛事的创新实践，更是凝聚家庭 与社会、运动与健康、体育与文旅协同发展的重要 ...